Company Search:
Advanced Search
Sponsored Links
Pulike Biological Engineering Inc Company Snapshot
Pulike Biological Engineering Inc operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Pulike Biological Engineering Inc with three other companies in this sector in China: Nanjing King-Friend Biochemical Pharmaceutical Co Ltd (2016 sales of 581.89 million Chinese Renmimbi [US$92.75 million] ), Zhenxing Biopharmaceutical & Chemical Co Ltd (567.44 million Chinese Renmimbi [US$90.44 million] of which 100% was Pharmaceutical Sales), and Walvax Biotechnology Company Limited (590.16 million Chinese Renmimbi [US$94.07 million] of which 38% was Autonomous Vaccine).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Pulike Biological Engineering Inc
  Stock Performance Chart for Pulike Biological Engineering Inc
  Stock Data: Recent Stock Performance:
  Current Price (4/20/2018): 19.82
(Figures in Chinese Renmimbi)
1 Week -3.4%   13 Weeks -2.2%  
4 Weeks -11.8%   52 Weeks -22.5%  
Pulike Biological Engineering Inc Key Data:
  Ticker: 603566 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2016 Sales 583,093,059
(Year Ending Jan 2017).
Employees: 1,233
  Currency: Chinese Renmimbi Market Cap: 6,342,400,000
  Fiscal Yr Ends: December Shares Outstanding: 320,000,000
  Share Type: GU Closely Held Shares: 216,197,472
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.